Your A-Z of episodes

Peruse previous podcasts and tune into the people and topics that spark your interest. Each episode offers a brief synopsis to help you select the conversation that best fits your schedule. With most episodes lasting around 40 minutes you can scan the sector and listen to leaders while you commute, exercise or grocery shop. Select your shot of infotainment.

  • Episode 95

    Top 5 episodes of all time

    Top 5 episodes

    / A look back episode

    Find out who topped the charts of the Molecule to Market podcast downloads, with highlights from our top 5 episodes.

  • Episode 94

    CPHI 2022 – Trends, challenges & opportunities

    CPHI Frankfurt 2022

    / A live episode

    Catch up on the latest new trends the life science industry sees coming next year, as well as advancements in the guests’ organizations.

  • Episode 93

    Views from AAPS 2022

    Views from AAPS

    / A live podcast

    Get the inside scoop on trends industry leaders foresee coming to life sciences in 2023.

  • Episode 92

    The Personalized Medicine Pioneer

    David Katz

    / Sparrow Pharmaceuticals, Inc.

    Find out more about life in a virtual biopharma company and the trials and tribulations on the pathway to commercialization.

  • Episode 91

    Inizio’s biotech bromance

    Jason McKenna and Dean McAlister

    / Inizio Biotech

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jason McKenna, Global President, and Dean McAlister, Executive Vice President both from Inizio Biotech. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with the dynamic duo, covering: A wealth of big pharma

  • Episode 90

    The Magic of Drug Development

    Marcelo Bigal

    / Ventus Therapeutics

    In this special episode of Molecule to Market, we go back inside the global drug development space with Marcelo Bigal, President and CEO, of Ventus Therapeutics, and Versant Venture Partner, who shares his journey from being a Neurologist to taking a drug to market with Teva Pharmaceuticals where is now CEO. Your host, Raman Sehgal,

  • Episode 89

    Why everything starts with great culture

    A listen back

    / on culture

    In this special repurposed episode of Molecule to Market, we go back inside the global drug development space with previous guests Magnus Gustafsson, Chief Business Officer at Biovian, Jeff Dill, CEO at Vynamic. , and Peter Soelkner, Managing Director at Vetter to hear their thoughts on building a great organisational culture.  Your host, Raman Sehgal,

  • Episode 88

    The orphan drug entrepreneur

    Evelyn Kelly

    / Orphan Drug Consulting

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Evelyn Kelly, Chief Executive Officer at Orphan Drug Consulting.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Evelyn, covering: A deep dive into the world of orphan drugs, rare diseases and personalised

  • Episode 87

    The wonder of Wurster technology

    Chuck Frey

    / Coating Place

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Chuck Frey, VP Scientific Affairs at Coating Place. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Chuck, covering: The backstory to Wurster coating technology and how it changed the world of

  • Episode 86

    Biotech trends you need to know

    Allan Shaw

    / Consulting CFO at various Biotech's

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with  Allan Shaw, Consulting CFO, Special Advisor & Board Member of several biotech companies. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Allan, covering: The sensitive cash position of biotech’s as a

  • Load more